Precision Medicine

Can We Now Track Cancer Using Only 5% Tumor DNA?
Tech & Innovation Can We Now Track Cancer Using Only 5% Tumor DNA?

Ivan Kairatov is a seasoned veteran in the biopharmaceutical sector, where he has spent years navigating the complex intersection of cutting-edge technology and clinical research. With an extensive background in research and development, Kairatov has gained a deep understanding of how innovation

Trend Analysis: AI Digital Twins in Rehabilitation
Tech & Innovation Trend Analysis: AI Digital Twins in Rehabilitation

The intricate dance between neural pathways and linguistic expression often collapses after a neurological event, leaving millions in a silent struggle that traditional medical practices have historically struggled to quantify with precision. With approximately 2 million Americans currently living

How Will CARA Redefine the Future of Retinal Diagnostics?
Tech & Innovation How Will CARA Redefine the Future of Retinal Diagnostics?

The global healthcare landscape is currently grappling with a dual crisis of aging demographics and a chronic shortage of specialized medical professionals who are capable of performing complex diagnostic procedures. In this environment, the emergence of artificial intelligence has transitioned

Live-Cell Target Engagement Assays Redefine Drug Discovery
Tech & Innovation Live-Cell Target Engagement Assays Redefine Drug Discovery

The long-standing struggle to bridge the gap between initial laboratory success and actual therapeutic effectiveness has led the pharmaceutical industry to fundamentally rethink how molecular interactions are measured. For many years, the standard approach involved testing potential drug compounds

Older Florida Men Face Double the Skin Cancer Death Rate
Research & Development Older Florida Men Face Double the Skin Cancer Death Rate

The golden years in Florida are often sold as a sun-drenched reward for a lifetime of hard work, yet for many older men, this idyllic landscape hides a silent and increasingly aggressive biological adversary. While the state has long been a sanctuary for retirees, recent epidemiological shifts have

Can New Targets Turn Rhabdomyosarcoma Into Healthy Muscle?
Research & Development Can New Targets Turn Rhabdomyosarcoma Into Healthy Muscle?

The medical community is currently witnessing a profound shift in how we approach the most aggressive childhood cancers, moving away from the blunt force of radiation toward the elegant precision of molecular reprogramming. Rhabdomyosarcoma, or RMS, remains a high-stakes challenge in pediatric

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later